NCT01229475

Brief Summary

Catheter ablation of persistent atrial fibrillation (AF) remains a challenging procedure. Even in experienced centres, repeat interventions are necessary in up to 70 of patients to achieve sinus rhythm at a long-term follow-up. While there is a consensus to perform pulmonary vein isolation (PVI) as a cornerstone for the ablation of paroxysmal and persistent AF ablation, different additional ablation strategies are used to achieve a modification of the substrate that perpetuates the arrhythmia: linear lesions (anterior and roof lines) or ablation of complex fractionated atrial electrograms (CFAE). In the stepwise approach PVI, CFAE ablation and/or LL are combined according to the presenting arrhythmia during procedure. The aim of the study is to determine whether there is a difference in terms of freedom from arrhythmia between a stepwise approach and a linear ablation for repeat procedure in patient with recurrence of persistent atrial fibrillation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for not_applicable atrial-fibrillation

Timeline
Completed

Started Oct 2010

Typical duration for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

October 26, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 27, 2010

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

March 1, 2013

Status Verified

February 1, 2013

Enrollment Period

3 years

First QC Date

October 26, 2010

Last Update Submit

February 28, 2013

Conditions

Keywords

Atrial fibrillationrecurrencerepeat procedurelinear ablationstepwise approach

Outcome Measures

Primary Outcomes (1)

  • Freedom from atrial arrhythmia

    Documented freedom from atrial arrhythmia (AF or AT) during follow-up.

Secondary Outcomes (1)

  • Procedural and safety data

Study Arms (2)

Stepwise approach

ACTIVE COMPARATOR

Stepwise approach for repeat AF ablation

Procedure: Ablation with stepwise approachProcedure: Linear ablation

Linear ablation

ACTIVE COMPARATOR

Linear ablation for repeat procedure in patients with recurrent atrial fibrillation

Procedure: Ablation with stepwise approachProcedure: Linear ablation

Interventions

Stepwise approach for repeat AF ablation

Linear ablationStepwise approach

Linear ablation for AF ablation

Linear ablationStepwise approach

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with recurrence of symptomatic persistent atrial fibrillation after at least one ablation procedure,
  • with the last ablation procedure at least 3 months ago.
  • at least one unsuccessful attempt of antiarrhythmic drug
  • oral anticoagulation for at least 4 weeks prior to ablation

You may not qualify if:

  • LA thrombus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Deutsches Herzzentrum München

Munich, 80636, Germany

RECRUITING

MeSH Terms

Conditions

Atrial FibrillationRecurrence

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Study Officials

  • Isabel Deisenhofer, MD

    Deutsches Herzzentrum München

    STUDY CHAIR
  • Sonia Ammar, MD

    Deutsches Herzzentrum München

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sonia Ammar, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 26, 2010

First Posted

October 27, 2010

Study Start

October 1, 2010

Primary Completion

October 1, 2013

Study Completion

December 1, 2013

Last Updated

March 1, 2013

Record last verified: 2013-02

Locations